Stress-related sleep disruptions are increasingly prevalent and often tied to dysregulated cortisol rhythms and disturbances in the orexin pathway—key regulators of wakefulness, stress response, and sleep architecture. In this webinar, Dr. Andy Franklyn-Miller, Chief Medical & Innovation Officer at Nuritas, will explore the emerging science behind peptide-based, non-hormonal sleep support.
Dr. Franklyn-Miller will walk attendees through the full discovery-to-clinical pipeline behind peptide-based sleep technology, including the use of AI-driven molecular docking, proteomic mapping, and precision peptide manufacturing. He will review in vitro and pre-clinical validation for gastrointestinal survivability, as well as human clinical data demonstrating improvements in stress parameters and sleep continuity.
Learning Objectives
- Understand how cortisol regulation impacts stress resilience and sleep quality
- Learn how molecular docking and AI accelerate peptide discovery
- Explore proteomic mapping and the manufacturing workflow behind the plant peptides
- Review in vitro and pre-clinical assessments supporting gastrointestinal survivability
- Examine human clinical trial outcomes related to sleep and stress parameters
